EAHAD/LinkedIn
Sep 5, 2025, 14:12
EAHAD Podcast: Reducing Pain and Distress in Children Receiving Emicizumab
EAHAD (The European Association for Haemophilia and Allied Disorders) posted on LinkedIn:
”New Podcast Alert! Join us for the latest “Meet the Author Interview” with Maj Friberg Birkedal, Chair of the EAHAD Nurses Committee, discussing how the Neria Guard infusion set may help reduce pain and distress for children receiving emicizumab. Drawing on real-world experience, she highlights why even small innovations can make a big difference in paediatric care.
Tune in now.”
Stay updated with Hemostasis Today.
-
Dec 21, 2025, 07:24Heghine Khachatryan: World Federation of Hemophilia Is Far More Than An Organization
-
Dec 21, 2025, 07:21Arsene Mekinian Announces New Expert Clinic for Refractory Hemato-Immunologic Diseases
-
Dec 21, 2025, 07:11Robrecht Knapen on Optimzing Recanalization in Acute Ischemic Stroke Patients
-
Dec 21, 2025, 06:54Afshin Moradi on TSH Level and Stroke Severity
-
Dec 21, 2025, 06:41Architha Reddy on Integrating rTMS with Speech-Language Therapy in Post-Stroke Aphasia
-
Dec 21, 2025, 06:28Siddarth Raajasekar on Neopterin Association with Stroke and Carotid Endarterectomy
-
Dec 20, 2025, 23:44Alen Emmanuel Joshy: CT Brain in Intracranial Hemorrhage
-
Dec 20, 2025, 23:37CSL Champions Global Equity in Rare Disease Diagnosis and Treatment
-
Dec 20, 2025, 23:22New Article by Mauricio Wajngarten Extended Anticoagulation After Unprovoked VTE